Health

Africans have authored just 3% of COVID-19 research

Africans have authored just 3% of COVID-19 research papers, despite the fact that 17% of the world's population lives in Africa, reveal two analyses, published in the online journal BMJ Global Health.

Diseases, Conditions, Syndromes

Pfizer/BioNTech first dose 85% effective after 2-4 weeks: study

The first dose of the Pfizer/BioNTech vaccination is 85 percent effective against coronavirus infection between two and four weeks after inoculation, according to a study published in the Lancet medical journal.

Vaccination

Hong Kong fast-tracks approval for China's Sinovac vaccine

Hong Kong's government on Thursday approved the Chinese-made Sinovac coronavirus vaccine after a panel of experts fast-tracked its recommendation despite comparatively low efficacy and limited published data.

Vaccination

Brazil aims to buy 30 mn Sputnik V, Covaxin shots

The Brazilian government announced Wednesday it was negotiating the purchase of 30 million coronavirus vaccine doses from Russia and India, after regulators made it easier for the treatments to win emergency-use authorizations.

page 15 from 40